Web-Based MES addresses pharmaceutical industry needs.June 30, 2008 -
With multiple language support and automatic batch rescaling tool, POMSnet(TM) optimizes pharmaceutical manufacturing performance by controlling and tracking all aspects of production; promoting best practices; and capturing critical data. POMStrace facilitates maintenance and tracking of inventory records for supplies used in clinical trials. In case of cancelled/recalled trial, it also reduces risks to patients by blocking dispensing and providing access to all logistical information.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Honeywell International, Inc., Customer Operations Group
1944 E. Sky Harbor Circle
Phoenix, AZ, 85034
USA
Honeywell Announces New Pharmaceutical MES Product Line Features That Improve Quality, Plant Performance
POMStrace Provides Unique Tracking Features for Clinical Trials to Reduce Patient Risk; Upgraded POMSnet Features Multiple Language Support, Better Material Handling
PHOENIX, June 17, 2008 - Honeywell (NYSE:HON) today announced two additions to its POMSnet(TM) web-based manufacturing execution system (MES) for the pharmaceutical industry: the latest platform upgrade of POMSnet and POMStrace, a new tracking technology that helps reduce patient risk by improving communication and response time during clinical trials.
POMSnet helps improve pharmaceutical manufacturing performance by controlling and tracking all aspects of production, promoting best practices, and capturing critical data for compliance, quality control and process improvement. The new POMSnet upgrade supports multiple languages and offers improved material handling and new recipe features that can reduce cycle times, roll-out time for new procedures, production errors and compliance costs. The new upgrade features a batch rescaling tool that automatically adjusts recipes to partial batch quantities and includes new weighing methods and dispensing rules for increased accuracy. The system can reduce production errors up to 50 percent.
The new POMSnet upgrade also includes integration with Honeywell's Procedure Analyst, an advanced software application that manages information about plans, production and supply chain performance. This integration allows pharmaceutical manufacturers to more effectively troubleshoot their batches for increased operational efficiency.
"There truly is no room for error in pharmaceutical manufacturing, and technology is needed that can help drug makers produce the highest-quality products while maintaining plant safety and meeting very strict regulatory compliance," said Ashish Gaikwad, global director for Advanced Solutions, Honeywell Process Solutions. "The new POMSnet upgrade was designed to run tighter processes while making the technology more user friendly. The new support for multiple languages enables customers worldwide to take advantage of this technology."
POMStrace reduces the effort to maintain and track inventory records for supplies used in clinical trials. The system provides up-to-date information on supply levels, including patient distribution. It also can reduce potential risks to patients in case of a cancelled or recalled trial by blocking dispensing and providing immediate access to all logistical information. The system produces a traceability record of each patient kit and provides complete accounting for all materials.
"As more drug makers transition from paper systems to electronic records, reducing the effort needed to maintain inventory records can save up to $30,000 per clinical trial, which quickly adds up for companies that may execute as many as 200 trials per year," said Gaikwad.
For more information about the POMSnet system and other Honeywell solutions that improve business performance, visit www.honeywell.com/ps.
Honeywell International is a $37 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit www.honeywell.com. Honeywell Process Solutions is part of Honeywell's Automation and Control Solutions group, a global leader in providing product and service solutions that improve efficiency and profitability, support regulatory compliance, and maintain safe, comfortable environments in homes, buildings and industry. For more information about Process Solutions, access www.honeywell.com/ps.
POMSnet(TM) is a trademark of Honeywell International Inc.
|
|
|
|
|
|
|
| 
